CTLA4 and hepatocellular carcinoma: For instance, in patients with NASH-related HCC the prevalence of CD4+ and CD8+ expressing the inhibitory receptor Cytotoxic T-Lymphocyte Antigen 4 (CTLA-4; CD152) is higher as compared with those suffering from viral-related HCC [116].